{"content":"<li class=\"n-box-item date-title\" data-end=\"1531281599\" data-start=\"1531195200\" data-txt=\"Monday, December 23, 2019\">Tuesday, July 10, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3369147\" data-ts=\"1531270187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369147-fresh-shots-in-trade-war-slam-futures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresh shots in trade war slam futures</a></h4><ul><li>The president <a href=\"https://www.ft.com/content/cac0ee28-849e-11e8-96dd-fa565ec55929\" target=\"_blank\">has begun the process</a> of slapping tariffs on another $200B of Chinese imports.</li><li>Among open markets, the Nikkei (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWJ' title='iShares MSCI Japan ETF'>EWJ</a>) is<font color='red'> lower by 1.4%</font>. The yuan is&nbsp;<font color='red'>down 0.6%</font>&nbsp;vs. the greenback, as is the aussie.</li><li>S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) and Nasdaq 100 (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) futures are&nbsp;<font color='red'>down 0.85%</font>. DJIA (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>) futures are&nbsp;<font color='red'>off 1%</font>.</li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a>, <a href='https://seekingalpha.com/symbol/YINN' title='Direxion Daily FTSE China Bull 3x Shares ETF'>YINN</a>, <a href='https://seekingalpha.com/symbol/FXA' title='Invesco CurrencyShares Australian Dollar Trust ETF'>FXA</a>, <a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a>, <a href='https://seekingalpha.com/symbol/MCHI' title='iShares MSCI China ETF'>MCHI</a>, <a href='https://seekingalpha.com/symbol/GXC' title='SPDR S&P China ETF'>GXC</a>, <a href='https://seekingalpha.com/symbol/CYB' title='WisdomTree Chinese Yuan ETF'>CYB</a>, <a href='https://seekingalpha.com/symbol/FXP-OLD' title='ProShares UltraShort FTSE China 25 ETF'>FXP-OLD</a>, <a href='https://seekingalpha.com/symbol/PGJ' title='Invesco Golden Dragon China Portfolio ETF'>PGJ</a>, <a href='https://seekingalpha.com/symbol/CN' title='Deutsche X-trackers Harvest MSCI All China Equity ETF'>CN</a>, <a href='https://seekingalpha.com/symbol/TDF' title='Templeton Dragon Fund'>TDF</a>, <a href='https://seekingalpha.com/symbol/CNY' title='Market Vectors Chinese Renminbi/USD ETN'>CNY</a>, <a href='https://seekingalpha.com/symbol/CHN' title='China Fund'>CHN</a>, <a href='https://seekingalpha.com/symbol/CXSE' title='WisdomTree China ex-State-Owned Enterprises ETF'>CXSE</a>, <a href='https://seekingalpha.com/symbol/XPP' title='ProShares Ultra FTSE China 25 ETF'>XPP</a>, <a href='https://seekingalpha.com/symbol/FCA' title='First Trust China AlphaDEX ETF'>FCA</a>, <a href='https://seekingalpha.com/symbol/YAO' title='Invesco China All-Cap ETF'>YAO</a>, <a href='https://seekingalpha.com/symbol/YXI' title='ProShares Short FTSE China 50 ETF'>YXI</a>, <a href='https://seekingalpha.com/symbol/CROC' title='ProShares UltraShort Australian Dollar ETF'>CROC</a>, <a href='https://seekingalpha.com/symbol/GCH' title='Greater China Fund'>GCH</a>, <a href='https://seekingalpha.com/symbol/FXCH' title='Invesco CurrencyShares Chinese Renminbi Trust ETF'>FXCH</a>, <a href='https://seekingalpha.com/symbol/JFC' title='JPMorgan China Region Fund, Inc.'>JFC</a>, <a href='https://seekingalpha.com/symbol/KGRN' title='KraneShares MSCI China Environment ETF'>KGRN</a>, <a href='https://seekingalpha.com/symbol/DAUD' title='VelocityShares Daily 4X Long USD vs. AUD ETN'>DAUD</a>, <a href='https://seekingalpha.com/symbol/FLCH' title='Franklin FTSE China ETF'>FLCH</a>, <a href='https://seekingalpha.com/symbol/UAUD' title='VelocityShares Daily 4X Long AUD vs. USD ETN'>UAUD</a>, <a href='https://seekingalpha.com/symbol/WCHN' title='WisdomTree ICBCCS S&P China 500 ETF'>WCHN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369147\" data-linked=\"Fresh shots in trade war slam futures\" data-tweet=\"$EWJ $SPY $QQQ - Fresh shots in trade war slam futures https://seekingalpha.com/news/3369147-fresh-shots-in-trade-war-slam-futures?source=tweet\" data-url=\"https://seekingalpha.com/news/3369147-fresh-shots-in-trade-war-slam-futures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>188&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369132\" data-ts=\"1531258617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCX\" target=\"_blank\">OCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369132-after-hours-gainers-losers-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (07/10/2018)</a></h4><ul>     <li><b>Top gainers&nbsp;</b><a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>&nbsp;<font color='green'>+53.5%.&nbsp;</font><a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a>&nbsp;<font color='green'>+9.7.&nbsp;</font><a href='https://seekingalpha.com/symbol/LNNFF' title='Line Corp.'>OTC:LNNFF</a>&nbsp;<font color='green'>+3.7%.&nbsp;</font><a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>&nbsp;<font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color='green'>+2.1%</font>.</li>     <li><strong>Top Losers&nbsp;</strong><a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-13.5%</font>. <a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>&nbsp;<font color='red'>-8.0%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/AIR' title='AAR Corporation'>AIR</a>&nbsp;<font color='red'>-2.8%.&nbsp;</font><a href='https://seekingalpha.com/symbol/AXIM' title='Axim Biotechnologies, Inc.'>OTCQB:AXIM</a>&nbsp;<font color='red'>-2.5%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>&nbsp;<font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369132\" data-linked=\"After Hours Gainers / Losers (07/10/2018)\" data-tweet=\"$OCX $OCX $VSAR-OLD - After Hours Gainers / Losers (07/10/2018) https://seekingalpha.com/news/3369132-after-hours-gainers-losers-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369132-after-hours-gainers-losers-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369119\" data-ts=\"1531256638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369119-biocryst-pharmaplus-9-idera-pharmaminus-6-merger-terminated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst Pharma +9%, Idera Pharma -6% as merger terminated</a></h4><ul>     <li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>)&nbsp;<font color='green'>+9.1%</font> after-hours but Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) <font color='red'>-6.5%</font> after BioCryst shareholders <a href=\"https://seekingalpha.com/pr/17212449-biocryst-pharmaceuticals-announces-termination-merger-agreement-idera-pharmaceuticals\" target=\"_blank\">voted against a proposed merger</a> of the two companies; a majority of IDRA stockholders voted in favor of the agreement.</li>     <li>\"The BioCryst board and management team remain       confident in BCX-7353 and our ability to execute on our plan and advance our programs,\" BCRX says in announcing the termination of the merger deal.</li>     <li>BCRX will <a href=\"https://seekingalpha.com/pr/17212448-idera-pharmaceuticals-announces-termination-merger-agreement-biocryst-pharmaceuticals\" target=\"_blank\">reimburse IDRA for $6M</a> in transaction-related expenses as a result of nixing the deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369119\" data-linked=\"BioCryst Pharma +9%, Idera Pharma -6% as merger terminated\" data-tweet=\"$BCRX $BCRX $IDRA - BioCryst Pharma +9%, Idera Pharma -6% as merger terminated https://seekingalpha.com/news/3369119-biocryst-pharmaplus-9-idera-pharmaminus-6-merger-terminated?source=tweet\" data-url=\"https://seekingalpha.com/news/3369119-biocryst-pharmaplus-9-idera-pharmaminus-6-merger-terminated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369102\" data-ts=\"1531254676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369102-oclaro-shareholders-approve-acquisition-lumentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oclaro shareholders approve acquisition by Lumentum</a></h4><ul><li>        Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) shareholders have <a href=\"https://seekingalpha.com/pr/17212480-oclaro-stockholders-approve-merger-agreement-lumentum\" target=\"_blank\">approved the acquisition</a> by Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) after a vote at today&rsquo;s stockholders&rsquo; meeting.</li><li>               Approximately 96.2% voted in favor of the merger, which represented about 65.6% of Oclaro&rsquo;s outstanding common stock. &nbsp;&nbsp;</li><li>               The deal is still expected to close in 2H subject to regulatory approval.&nbsp;</li><li>               Oclaro shares are&nbsp;<font color='red'>down 0.3%</font>&nbsp;aftermarket to $9.01.&nbsp;</li><li>               Lumentum shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $56.78.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343906-ftc-clears-lumentums-deal-oclaro\" target=\"_blank\">FTC clears Lumentum's deal for Oclaro</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369102\" data-linked=\"Oclaro shareholders approve acquisition by Lumentum\" data-tweet=\"$OCLR $OCLR $LITE - Oclaro shareholders approve acquisition by Lumentum https://seekingalpha.com/news/3369102-oclaro-shareholders-approve-acquisition-lumentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3369102-oclaro-shareholders-approve-acquisition-lumentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369095\" data-ts=\"1531254167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRE\" target=\"_blank\">SRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369095-sempra-energy-to-launch-offerings-of-common-stock-convertible-preferreds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sempra Energy to launch offerings of common stock, convertible preferreds</a></h4><ul>     <li>Sempra Energy (NYSE:<a href='https://seekingalpha.com/symbol/SRE' title='Sempra Energy'>SRE</a>) <font color='red'>-2.5%</font> after-hours on news it plans to launch <a href=\"https://seekingalpha.com/pr/17212492-sempra-energy-announces-proposed-public-offerings-common-stock-mandatory-convertible\" target=\"_blank\">concurrent public offerings</a> of $1.1B of common shares in connection with the forward sale agreements and $500M of shares of mandatory convertible preferred stock.</li>     <li>SRE expects to grant the underwriters options to purchase an additional $165M of common shares and an additional $75M of shares of the convertible preferred stock.</li>     <li>SRE plans to use the proceeds from the offerings to repay outstanding commercial paper, to fund working capital and for other general corporate purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369095\" data-linked=\"Sempra Energy to launch offerings of common stock, convertible preferreds\" data-tweet=\"$SRE - Sempra Energy to launch offerings of common stock, convertible preferreds https://seekingalpha.com/news/3369095-sempra-energy-to-launch-offerings-of-common-stock-convertible-preferreds?source=tweet\" data-url=\"https://seekingalpha.com/news/3369095-sempra-energy-to-launch-offerings-of-common-stock-convertible-preferreds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369093\" data-ts=\"1531254077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369093-arqule-readies-stock-offering-shares-down-7-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule readies stock offering; shares down 7% after hours</a></h4><ul><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) is down&nbsp;<font color='red'>7%&nbsp;</font>after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17212505-arqule-announces-commencement-proposed-public-offering-common-stock\" target=\"_blank\">planned public offering </a>of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369093\" data-linked=\"ArQule readies stock offering; shares down 7% after hours\" data-tweet=\"$ARQL - ArQule readies stock offering; shares down 7% after hours https://seekingalpha.com/news/3369093-arqule-readies-stock-offering-shares-down-7-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3369093-arqule-readies-stock-offering-shares-down-7-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369086\" data-ts=\"1531253573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369086-pricing-transparency-law-in-california-effect-drug-makers-nix-planned-increases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pricing transparency law in California having effect, drug makers nix planned increases</a></h4><ul><li>Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2018-07-10/drugmakers-cancel-price-hikes-as-california-law-takes-effect\" target=\"_blank\">reports </a>that some drug firms have axed plans to increase pricing for certain products or have rolled back hikes in response to a new law in California aimed at pricing transparency. The law, requiring drug makers to give advance notice of significant price increases, is designed to pressure companies to keep prices down. It appears to be working.</li><li>In the past several weeks, Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>), Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>), Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) and Novo Nordisk (NYSE:<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a>) have notified California health plans rolling back or reducing price hikes on at least 10 drugs.</li><li>Pharma companies are far from accepting the new reality, however. Its lobbying group, Pharmaceutical Research and Manufacturers of America, is challenging the law in court.</li><li>Selected tickers: <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a>, <a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a>, <a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a>, <a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a>, <a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a>, <a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>, <a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>, <a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>, <a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>, <a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>, <a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>, <a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>, <a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>, <a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>, <a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>, <a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>, <a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>, VRX, <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369086\" data-linked=\"Pricing transparency law in California having effect, drug makers nix planned increases\" data-tweet=\"$NVS $NVS $GILD - Pricing transparency law in California having effect, drug makers nix planned increases https://seekingalpha.com/news/3369086-pricing-transparency-law-in-california-effect-drug-makers-nix-planned-increases?source=tweet\" data-url=\"https://seekingalpha.com/news/3369086-pricing-transparency-law-in-california-effect-drug-makers-nix-planned-increases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>137&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369074\" data-ts=\"1531253150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZK\" target=\"_blank\">OZK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369074-bank-earnings-may-rise-stocks-arent-following\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank earnings may rise, but stocks aren&#39;t following</a></h4><ul><li>As <a href=\"https://www.marketwatch.com/story/bank-earnings-are-expected-to-shine-but-their-stocks-may-not-2018-07-10\" target=\"_blank\">analysts expect banks' Q2 earnings</a> to provide good news when they start kicking in on Friday, their stocks aren't reflecting that optimism today--possibly due to concern over the flattening yield curve and trade tariff drama.</li><li>After three days of gains, the bank-heavy Financial Select Sector SPDR ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>) is&nbsp;<font color='red'>down 0.3%</font>,while the S&amp;P 500 Banks Industry Group Total Return Index&nbsp;<font color='red'>dips 0.6%</font>.</li><li>Regional banks, especially, seem a little more affected than the bigger banks. Bank of the Ozarks (OZRK <font color='red'>-1.3%</font>), Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='red'>-1.1%</font>), and Huntington Bancshares (<a href='https://seekingalpha.com/symbol/HBAN' title='Huntington Bancshares Incorporated'>HBAN</a> <font color='red'>-1.6%</font>) all lost more than 1% in late trading.</li><li>Among the big banks, Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-1.1%</font>) was the weakest. Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-0.8%</font>) was the most active stock by volume in U.S. trading.</li><li>U.S. 10-year Treasury yield exceeds the 2-year yield by just 28 basis points compared with about 35 basis points about two weeks ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368714-banks-climb-third-day-anticipating-strong-earnings\" target=\"_blank\">Banks climb for third day anticipating strong earnings</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369074\" data-linked=\"Bank earnings may rise, but stocks aren&#39;t following\" data-tweet=\"$OZK $XLF $OZK - Bank earnings may rise, but stocks aren&#39;t following https://seekingalpha.com/news/3369074-bank-earnings-may-rise-stocks-arent-following?source=tweet\" data-url=\"https://seekingalpha.com/news/3369074-bank-earnings-may-rise-stocks-arent-following\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369068\" data-ts=\"1531252865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369068-mattress-stock-weak-after-wedbush-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattress stock weak after Wedbush warns</a></h4><ul><li>Tempur Sealy (<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='red'>-8.8%</font>) and Sleep Number (<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a> <font color='red'>-3.4%</font>) trade lower after Wedbush warns that the mattress sellers could fall short with their Q2 earnings reports.</li><li>Sleep Number is the first up to report numbers on July 25, while Tempur Sealy is expected to post results in early August.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369068\" data-linked=\"Mattress stock weak after Wedbush warns\" data-tweet=\"$TPX $TPX $SNBR - Mattress stock weak after Wedbush warns https://seekingalpha.com/news/3369068-mattress-stock-weak-after-wedbush-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/3369068-mattress-stock-weak-after-wedbush-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369065\" data-ts=\"1531252138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369065-cummins-upped-to-buy-stifel-on-stronger-for-longer-truck-equipment-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cummins upped to Buy at Stifel on &#39;stronger for longer&#39; truck equipment view</a></h4><ul>     <li>Cummins (<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color='green'>+1.5%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/CMIid2755844/CMI-Stifel-upgrades-Cummins-to-Buy-on-stronger-for-longer-view-of-truck-equipment\" target=\"_blank\">upgraded to Buy</a> from Hold at Stifel, which says shares of truck equipment companies have been under pressure primarily on concerns that the cycle is at a peak.</li>     <li>But Stifel analyst Michael Baudendistel holds a \"stronger for longer\" outlook on the truck equipment market, mainly due to robust freight rates, and he highlights CMI's potential to utilize its balance sheet to complete one or more transformative acquisitions.</li><li>But the firm cuts its CMI price target to $160 from $174, noting that the company's end markets are generally at higher than average points in their respective cycles.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369065\" data-linked=\"Cummins upped to Buy at Stifel on &#39;stronger for longer&#39; truck equipment view\" data-tweet=\"$CMI - Cummins upped to Buy at Stifel on &#39;stronger for longer&#39; truck equipment view https://seekingalpha.com/news/3369065-cummins-upped-to-buy-stifel-on-stronger-for-longer-truck-equipment-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3369065-cummins-upped-to-buy-stifel-on-stronger-for-longer-truck-equipment-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369058\" data-ts=\"1531251023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIO\" target=\"_blank\">PHIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369058-rxi-pharma-breaks-downtrend-up-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RXi Pharma breaks downtrend, up 23%</a></h4><ul><li>Thinly traded nano cap RXi Pharmaceuticals (RXII <font color='green'>+22.8%</font>) is up on almost a 4x surge in volume. Shares had been in a downtrend since a brief rally in March, shedding 70% of their value since touching $6.76 on March 15.</li><li>This morning, collaboration partner BioAxone BioSciences <a href=\"https://seekingalpha.com/pr/17204415-bioaxone-biosciences-awarded-1_1-million-phase-2-sbir-funding-continued-development-sd-rxrna\" target=\"_blank\">announced </a>that the National Institute of Neurological Disorders and Stroke awarded it a $1.1M grant to fund the continued development of BA-434 for the treatment of spinal cord injury. RXi will receive ~$119K of the award for its contribution.</li><li>On the capital front, RXi had $2.6M in cash at the end of March while operations consumed $1.9M during the quarter. In April, the company executed a stock offering that raised net proceeds of $4.1M. Operations consumed an average of $2.4M of cash per quarter in 2017 so more capital will be needed before year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369058\" data-linked=\"RXi Pharma breaks downtrend, up 23%\" data-tweet=\"$PHIO - RXi Pharma breaks downtrend, up 23% https://seekingalpha.com/news/3369058-rxi-pharma-breaks-downtrend-up-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3369058-rxi-pharma-breaks-downtrend-up-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369059\" data-ts=\"1531250891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPYR\" target=\"_blank\">SPYR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369059-spyr-signs-loi-to-acquire-highly-accretive-online-game\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SPYR signs LOI to acquire highly accretive online game</a></h4><ul>     <li>SPYR (<a href='https://seekingalpha.com/symbol/SPYR' title='SPYR, Inc.'>OTCPK:SPYR</a> <font color='green'>+10%</font>) has signed an  asset purchase Letter of Intent (LOI) to acquire a popular massively multiplayer online role-playing game or MMORPG.</li>     <li>The target company currently generates more than $9M in annual revenue (unaudited information).</li>     <li>Upon closing of the transaction, SPYR will acquire all of the game assets, including the game&rsquo;s experienced development team.</li>     <li>Mike Turner, SPYR&rsquo;s VP of Strategic Partnerships states, &ldquo;This highly accretive acquisition will result in SPYR generating meaningful pro forma revenue and cash flow\".</li>     <li><a href=\"https://seekingalpha.com/pr/17211590-spyr-commences-roll-strategy-signing-letter-intent-acquire-highly-accretive-online-game\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3369059\" data-linked=\"SPYR signs LOI to acquire highly accretive online game\" data-tweet=\"$SPYR - SPYR signs LOI to acquire highly accretive online game https://seekingalpha.com/news/3369059-spyr-signs-loi-to-acquire-highly-accretive-online-game?source=tweet\" data-url=\"https://seekingalpha.com/news/3369059-spyr-signs-loi-to-acquire-highly-accretive-online-game\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369056\" data-ts=\"1531250488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGIC\" target=\"_blank\">MGIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369056-magic-softwareplus-5_8-on-earning-microsoft-partner-status\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magic Software +5.8% on earning Microsoft Partner status</a></h4><ul><li>        Magic Software (NASDAQ:<a href='https://seekingalpha.com/symbol/MGIC' title='Magic Software Enterprises Ltd.'>MGIC</a>)&nbsp;<font color='green'>gains 5.8%</font>&nbsp;to $8.68 after <a href=\"https://seekingalpha.com/filing/4095923\" target=\"_blank\">announcing</a> it earned co-sell ready status through the Microsoft One Commercial Partner program.</li><li>               The status applies to the Magic xpi integration platform and Magic xpc cloud-based iPaaS. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369056\" data-linked=\"Magic Software +5.8% on earning Microsoft Partner status\" data-tweet=\"$MGIC - Magic Software +5.8% on earning Microsoft Partner status https://seekingalpha.com/news/3369056-magic-softwareplus-5_8-on-earning-microsoft-partner-status?source=tweet\" data-url=\"https://seekingalpha.com/news/3369056-magic-softwareplus-5_8-on-earning-microsoft-partner-status\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369051\" data-ts=\"1531248931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTSL\" target=\"_blank\">MTSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369051-technology-top-5-gainers-losers-of-2_55-pm-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (07/10/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+116%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+114%</font>. <a href='https://seekingalpha.com/symbol/BDR' title='Blonder Tongue Laboratories, Inc'>BDR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a> <font color='green'>+10%</font>.</li>      <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BKTI' title='RELM Wireless Corporation'>BKTI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RDVT' title='Red Violet, Inc.'>RDVT</a> <font color='red'>-9%</font>.</li><br></ul><div class=\"tiny-share-widget\" data-id=\"3369051\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (07/10/2018)\" data-tweet=\"$MTSL $MTSL $BLIN - Technology - Top 5 Gainers / Losers as of 2.55 PM (07/10/2018) https://seekingalpha.com/news/3369051-technology-top-5-gainers-losers-of-2_55-pm-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369051-technology-top-5-gainers-losers-of-2_55-pm-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369045\" data-ts=\"1531246593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369045-google-launches-retail-ad-tool-shopify\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google launches a retail ad tool with Shopify</a></h4><ul><li>        Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.2%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2018-07-10/google-works-with-shopify-to-spur-commerce-retail-ad-spending?utm_campaign=socialflow-organic&amp;utm_content=tech&amp;cmpid==socialflow-twitter-tech&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">launching a new commerce tool</a> to make it easier for retailers to run shopping ads.</li><li>               The ads will appear on several Google services and marketers can purchase the spots through Google or Shopify (<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a> <font color='green'>+0.2%</font>). &nbsp;&nbsp;</li><li>               Retailers can set business goals for the ads, such as getting new customers or driving traffic, and that can help Google target the ads across search results, Maps, YouTube, and elsewhere on the web. &nbsp;&nbsp;</li><li>               The retail feature is one of four new ad products Google launched today. The suite also includes responsive search ads, which allows marketers to use more words and as many as 15 different headlines to pitch to customers. Google selects the best words/headlines based on frequently used search terms.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368734-reuters-eu-android-fine-decision-pushed-back-trump-visits\" target=\"_blank\">Reuters: EU Android fine decision pushed back as Trump visits</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369045\" data-linked=\"Google launches a retail ad tool with Shopify\" data-tweet=\"$GOOG $GOOG $GOOGL - Google launches a retail ad tool with Shopify https://seekingalpha.com/news/3369045-google-launches-retail-ad-tool-shopify?source=tweet\" data-url=\"https://seekingalpha.com/news/3369045-google-launches-retail-ad-tool-shopify\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369038\" data-ts=\"1531245647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369038-energy-materials-top-5-gainers-losers-of-2-00-pm-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369038\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/10/2018)\" data-tweet=\"$GBR $GBR $EGY - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/10/2018) https://seekingalpha.com/news/3369038-energy-materials-top-5-gainers-losers-of-2-00-pm-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369038-energy-materials-top-5-gainers-losers-of-2-00-pm-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369030\" data-ts=\"1531242600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTAI\" target=\"_blank\">BTAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369030-bioxcel-new-high-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioXcel at new high, up 14%</a></h4><ul><li>Relatively recent IPO BioXcel Therapeutics (<a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics'>BTAI</a> <font color='green'>+14.4%</font>) has cleared resistance on modestly higher volume, albeit on turnover of only 56K shares, to reach its highest point since its U.S. debut on March 8.</li><li>Earlier today, the company <a href=\"https://seekingalpha.com/pr/17211439-bioxcel-therapeutics-forms-neuroscience-clinical-advisory-board-support-global-development\" target=\"_blank\">announced </a>the formation of a Clinical Advisory Board that will counsel management on lead candidate BXCL501 as it advances through clinical development for the treatment of agitation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337608-bioxcel-therapeutics-prices-ipo-11\" target=\"_blank\">BioXcel Therapeutics prices IPO at $11</a> (March 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369030\" data-linked=\"BioXcel at new high, up 14%\" data-tweet=\"$BTAI - BioXcel at new high, up 14% https://seekingalpha.com/news/3369030-bioxcel-new-high-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3369030-bioxcel-new-high-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369026\" data-ts=\"1531242068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMPL\" target=\"_blank\">SMPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369026-financials-top-gainers-losers-of-1-00-pm-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (07/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SMPL' title='The Simply Good Foods Company'>SMPL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CLPR' title='Clipper Realty Inc'>CLPR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369026\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (07/10/2018)\" data-tweet=\"$SMPL $SMPL $CLPR - Financials - Top Gainers / Losers as of 1:00 PM (07/10/2018) https://seekingalpha.com/news/3369026-financials-top-gainers-losers-of-1-00-pm-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369026-financials-top-gainers-losers-of-1-00-pm-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369023\" data-ts=\"1531241535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLIN\" target=\"_blank\">BLIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369023-midday-gainers-losers-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/10/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+132%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+110%</font>. <a href='https://seekingalpha.com/symbol/INSP' title='Inspire Medical Systems, Inc.'>INSP</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics'>BTAI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='green'>+12%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='red'>-12%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369023\" data-linked=\"Midday Gainers / Losers (07/10/2018)\" data-tweet=\"$BLIN $BLIN $MTSL - Midday Gainers / Losers (07/10/2018) https://seekingalpha.com/news/3369023-midday-gainers-losers-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369023-midday-gainers-losers-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369020\" data-ts=\"1531240911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNTR-OLD\" target=\"_blank\">TNTR-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369020-tintriplus-15_3-on-chapter-11-filing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tintri +15.3% on Chapter 11 filing</a></h4><ul><li>        Tintri (NASDAQ:<a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a>) <a href=\"https://seekingalpha.com/pr/17212237-tintri-announces-bankruptcy-filing-non-binding-letter-intent-financing-commitment\" target=\"_blank\">announces</a> filing for Chapter 11. The company will continue operating as a debtor-in-possession under the bankruptcy court&rsquo;s jurisdiction.</li><li>               Tintri confirms entering into a letter of intent with DataDirect Networks to purchase its assets. The letter is non-binding, and Tintri notes that any proceeds might not be enough to pay off its creditors.&nbsp;</li><li>               Tintri doesn&rsquo;t expect stockholders to receive any return on their shares.&nbsp;</li><li>               Tintri shares are&nbsp;<font color='green'>up 15.3%</font>&nbsp;to $0.21.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368966-datadirect-networks-stages-bid-acquire-tintri-s-assets-expand-storage-portfolio-enterprise\" target=\"_blank\">DataDirect Networks stages bid to acquire Tintri&rsquo;s assets and expand its storage portfolio into the enterprise</a> (July 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369020\" data-linked=\"Tintri +15.3% on Chapter 11 filing\" data-tweet=\"$TNTR-OLD - Tintri +15.3% on Chapter 11 filing https://seekingalpha.com/news/3369020-tintriplus-15_3-on-chapter-11-filing?source=tweet\" data-url=\"https://seekingalpha.com/news/3369020-tintriplus-15_3-on-chapter-11-filing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369018\" data-ts=\"1531240322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369018-bofaml-raises-apple-target-on-8b-ar-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML raises Apple target on $8B AR potential</a></h4><ul><li>        Augmented reality could be an $8B revenue opportunity for Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>), <a href=\"https://www.cnbc.com/2018/07/10/augmented-reality-could-be-an-8-billion-revenue-opportunity-for-app.html\" target=\"_blank\">according</a> to Bank of America Merrill Lynch.</li><li>               Analyst Wamsi Mohan says AR apps and increased iPhone sales due to the tech could create $6B to $8B in additional revenue within the next two years. Apps are expected to contribute $1B of the total.&nbsp;</li><li>               The analyst puts the revenue upside as high as $11B if Apple introduces AR-specific glasses.&nbsp;</li><li>               Firm reiterates its Buy rating and raises its Apple price target by $5 to $230, a 21% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;to $191.12. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369018\" data-linked=\"BofAML raises Apple target on $8B AR potential\" data-tweet=\"$AAPL - BofAML raises Apple target on $8B AR potential https://seekingalpha.com/news/3369018-bofaml-raises-apple-target-on-8b-ar-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3369018-bofaml-raises-apple-target-on-8b-ar-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369015\" data-ts=\"1531240085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTSSF\" target=\"_blank\">FTSSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369015-first-cobaltplus-15-after-identifying-second-kerr-cobalt-mineralization-trend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Cobalt +15% after identifying second Kerr cobalt mineralization trend</a></h4><ul>     <li>First Cobalt (<a href='https://seekingalpha.com/symbol/FTSSF' title='First Cobalt Corp'>OTCQX:FTSSF</a> <font color='green'>+15.2%</font>) jumps after saying drilling in the Canadian Cobalt Camp in Ontario <a href=\"https://www.firstcobalt.com/investors/news/first-cobalt-identifies-second-cobalt-mineralization--trend-in-kerr-area-of-cobalt-camp-\" target=\"_blank\">identified a second cobalt mineralization trend</a> within the Kerr area extending over a 500-meter strike length.</li>     <li>First Cobalt reports finding several mineralized intervals near the Drummond and Kerr Lake mines containing multiple closely spaced cobalt-silver veins.</li>     <li>President and CEO Trent Mell says the company is reallocating a larger portion of its 2018 exploration budget to the Kerr area despite having many prospective targets; results from nine drill holes are pending and additional drilling is planned.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369015\" data-linked=\"First Cobalt +15% after identifying second Kerr cobalt mineralization trend\" data-tweet=\"$FTSSF - First Cobalt +15% after identifying second Kerr cobalt mineralization trend https://seekingalpha.com/news/3369015-first-cobaltplus-15-after-identifying-second-kerr-cobalt-mineralization-trend?source=tweet\" data-url=\"https://seekingalpha.com/news/3369015-first-cobaltplus-15-after-identifying-second-kerr-cobalt-mineralization-trend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369010\" data-ts=\"1531239253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369010-box-acquires-intelligent-search-company-butter-ai\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box acquires intelligent search company Butter.ai</a></h4><ul><li>        Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>)<a href=\"https://blog.box.com/blog/welcome-butter-ai-team-Box/\" target=\"_blank\"> acquires</a> cloud-based intelligent search company Butter.ai for undisclosed terms.</li><li>               The Butter.ai team will join Box and help bring more intelligence to the search capabilities within the Box product.&nbsp;</li><li>               Evernote veterans <a href=\"https://techcrunch.com/2018/07/10/box-acquires-butter-ai-to-make-search-smarter/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">founded</a> Butter.ai, which until now worked as a search assistant inside Slack.&nbsp;</li><li>               The startup raised $3.3M in two seed rounds with participation from Slack and General Catalyst.&nbsp;</li><li>               Box shares are&nbsp;<font color='red'>down 0.3%</font>&nbsp;to $26.52.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369010\" data-linked=\"Box acquires intelligent search company Butter.ai\" data-tweet=\"$BOX - Box acquires intelligent search company Butter.ai https://seekingalpha.com/news/3369010-box-acquires-intelligent-search-company-butter-ai?source=tweet\" data-url=\"https://seekingalpha.com/news/3369010-box-acquires-intelligent-search-company-butter-ai\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369009\" data-ts=\"1531238913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369009-boeing-beats-airbus-460-net-first-half-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing beats Airbus with 460 net first-half orders</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.5%</font>) says it <a href=\"https://www.reuters.com/article/us-boeing-deliveries/boeing-first-half-orders-more-than-double-that-of-airbus-idUSKBN1K025F\" target=\"_blank\">recorded 460 net aircraft orders</a> after cancellations in the six months through June, well ahead of rival Airbus' (<a href='https://seekingalpha.com/symbol/EADSF' title='Airbus SE'>OTCPK:EADSF</a>, <a href='https://seekingalpha.com/symbol/EADSY' title='Airbus SE ADR'>OTCPK:EADSY</a>) 206 during the same period.</li>     <li><a href=\"https://seekingalpha.com/pr/17212122-boeing-reports-second-quarter-deliveries\" target=\"_blank\">H1 deliveries</a> rose 7.4% Y/Y to 378 commercial aircraft, led by strong demand for its single-aisle 737 jetliners, while total Q2 deliveries gained 6% Y/Y to 194.</li>     <li><a href=\"https://seekingalpha.com/news/3368170-airbus-reports-303-jetliners-delivered-h1\" target=\"_blank\">Last week</a>, Airbus said it delivered 303 aircraft during H1, 1% lower than the prior-year period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369009\" data-linked=\"Boeing beats Airbus with 460 net first-half orders\" data-tweet=\"$BA $BA $EADSF - Boeing beats Airbus with 460 net first-half orders https://seekingalpha.com/news/3369009-boeing-beats-airbus-460-net-first-half-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/3369009-boeing-beats-airbus-460-net-first-half-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369005\" data-ts=\"1531238668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369005-cristiano-ronaldo-implications-in-italy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cristiano Ronaldo implications in Italy</a></h4><ul> <li>The transfer of Real Madrid soccer superstar Cristiano Ronaldo to Juventus is <a href=\"https://www.bloomberg.com/news/articles/2018-07-10/real-madrid-has-agreed-to-transfer-cristiano-ronaldo-to-juventus.\" target=\"_blank\">official</a>, reports Bloomberg.</li> <li>The signing of Ronaldo is creating some <a href=\"http://www.marca.com/en/football/real-madrid/2018/07/08/5b4138e3268e3e66758b4678.html\" target=\"_blank\">headaches</a> for Fiat Chrysler Automobiles (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) in Italy due to the company's willingness to help finance the &euro;100M deal. The common link between Fiat and the soccer club is the Agnelli family which owns 29%&nbsp; of Fiat and 64% of Juventus. A few social media campaigns against Fiat on the behalf of workers have already started.</li> <li>Shares of Juventus Football Club (<a href='https://seekingalpha.com/symbol/JVTSF' title='JUVENTUS FOOTBALL CLUB SPA, TORINO'>OTCPK:JVTSF</a>)&nbsp;<font color='green'>gained another 5.54%</font>&nbsp;in Milan today and are up more than 30% since the Ronaldo pursuit began to heat up. Some European analysts think the rally was too much, too soon.</li><li>There is also some speculation that Ronaldo playing in Italy could lead to a sponsorship deal with Ferrari (NYSE:<a href='https://seekingalpha.com/symbol/RACE' title='Ferrari N.V.'>RACE</a>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369005\" data-linked=\"Cristiano Ronaldo implications in Italy\" data-tweet=\"$FCAU $FCAU $JVTSF - Cristiano Ronaldo implications in Italy https://seekingalpha.com/news/3369005-cristiano-ronaldo-implications-in-italy?source=tweet\" data-url=\"https://seekingalpha.com/news/3369005-cristiano-ronaldo-implications-in-italy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369003\" data-ts=\"1531238481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THST\" target=\"_blank\">THST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369003-consumer-top-gainers-losers-of-12-00-pm-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (07/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/JRSH' title='Jerash Holdings &#40;US&#41; Inc'>JRSH</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PRPL' title='Purple Innovation, Inc.'>PRPL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369003\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (07/10/2018)\" data-tweet=\"$THST $THST $KOSS - Consumer - Top Gainers / Losers as of 12:00 PM (07/10/2018) https://seekingalpha.com/news/3369003-consumer-top-gainers-losers-of-12-00-pm-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369003-consumer-top-gainers-losers-of-12-00-pm-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368990\" data-ts=\"1531237801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRIF\" target=\"_blank\">GRIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368990-on-griffin-industrial-realtys-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Griffin Industrial Realty&#39;s Q2 results</a></h4><ul><li>Griffin Industrial Realty (NASDAQ:<a href='https://seekingalpha.com/symbol/GRIF' title='Griffin Industrial Realty, Inc.'>GRIF</a>) reported Q2 revenue decrease of 49.8% Y/Y to $9.09M, reflecting a decrease in revenue from property sales partially offset by an increase in rental revenue.</li><li>Segment revenue: Rental $8.19M (+11.7% Y/Y) and property sales $0.89M (-91.6% Y/Y), property sales occur periodically, and year to year changes in revenue and gains from property sales may not be indicative of any trends in the company&rsquo;s real estate business.</li><li>Q2 Operating margin&nbsp;<font color='red'>declined by 2,705 bps</font>&nbsp;to 20.9%.</li><li>G&amp;A expenses were $1.84M (-15.24% Y/Y), decrease reflects write-off of costs related to a land purchase that was not completed in the 2Q17.</li><li>Profit from leasing activities was $5.78M (+12.7% Y/Y).</li><li>Rental portfolio has 35 buildings with ~3.17M sq ft. which is 94% leased as of May 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368883-griffin-industrial-realty-reports-q2-results\" target=\"_blank\">Griffin Industrial Realty reports Q2 results</a> (July 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368990\" data-linked=\"More on Griffin Industrial Realty&#39;s Q2 results\" data-tweet=\"$GRIF - More on Griffin Industrial Realty&#39;s Q2 results https://seekingalpha.com/news/3368990-on-griffin-industrial-realtys-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3368990-on-griffin-industrial-realtys-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368995\" data-ts=\"1531237212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLB\" target=\"_blank\">DLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368995-dolby-labs-appoints-samsung-vet-cmo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dolby Labs appoints Samsung vet as CMO</a></h4><ul><li>        Dolby Labs (NYSE:<a href='https://seekingalpha.com/symbol/DLB' title='Dolby Laboratories, Inc.'>DLB</a>) <a href=\"https://seekingalpha.com/pr/17212152-dolby-laboratories-names-todd-pendleton-chief-marketing-officer\" target=\"_blank\">appoints</a> Todd Pendleton as SVP and CMO.</li><li>               Pendleton spent 15 years at Nike in marketing and was CMO of Samsung North America. &nbsp;&nbsp;</li><li>               Dolby shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;to $62.89.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368995\" data-linked=\"Dolby Labs appoints Samsung vet as CMO\" data-tweet=\"$DLB - Dolby Labs appoints Samsung vet as CMO https://seekingalpha.com/news/3368995-dolby-labs-appoints-samsung-vet-cmo?source=tweet\" data-url=\"https://seekingalpha.com/news/3368995-dolby-labs-appoints-samsung-vet-cmo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368992\" data-ts=\"1531237025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCB\" target=\"_blank\">ARCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368992-wolfe-research-check-in-on-logistics-sector-ahead-of-q2-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wolfe Research check in on logistics sector ahead of Q2 earnings</a></h4><ul> <li>Wolfe Research updates on trends in the logistics sector.</li> <li>\"Freight volumes in 2Q remained very strong and pricing trends are accelerating, so we have high expectations for 2Q reports and expect many more beats than misses this quarter,\" writes analyst Scott Group.</li> <li>As it looks to Q2 earnings reports, Wolfe is most above consensus on ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='red'>-0.9%</font>), Heartland Express (<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a> <font color='red'>-0.9%</font>), YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='red'>-0.6%</font>) and Hub Group (<a href='https://seekingalpha.com/symbol/HUBG' title='Hub Group, Inc.'>HUBG</a> <font color='red'>-0.3%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368992\" data-linked=\"Wolfe Research check in on logistics sector ahead of Q2 earnings\" data-tweet=\"$ARCB $ARCB $HTLD - Wolfe Research check in on logistics sector ahead of Q2 earnings https://seekingalpha.com/news/3368992-wolfe-research-check-in-on-logistics-sector-ahead-of-q2-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3368992-wolfe-research-check-in-on-logistics-sector-ahead-of-q2-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368991\" data-ts=\"1531236928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368991-susquehanna-to-altaba-cut-bait-on-yahoo-japan-focus-on-alibaba\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna to Altaba: Cut bait on Yahoo Japan, focus on Alibaba</a></h4><ul>   <li>Fresh off a <a href=\"https://seekingalpha.com/news/3368783-yahoo-japan-plans-buyback-three-way-deal-altaba-softbank\" target=\"_blank\">three-way deal</a> that sees Altaba (NASDAQ:<a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a>) selling about a third of its stake in Yahoo Japan (<a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a>), Susquehanna urges Altaba to sell the rest and focus on monetizing its share of Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>).</li>    <li>The Yahoo Japan portion has gone poorly for Altaba, which is selling at a multi-year low, and it's time for \"cutting bait\" and focusing on a deal with Alibaba, writes analyst Joseph Stauff. There's upside of $8-$12/share in an Alibaba transaction against $2/share in downside. (h/t Bloomberg)</li>    <li>Yahoo Japan's buyback is being facilitated by major shareholder SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>), which is buying Yahoo Japan shares from Altaba before selling them back to Yahoo Japan.</li>    <li>In U.S. trading today: <a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a> <font color='green'>+5.3%</font>; <a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a> <font color='green'>+1%</font>; <a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='green'>+0.4%</font>; <a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a> <font color='green'>+1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368991\" data-linked=\"Susquehanna to Altaba: Cut bait on Yahoo Japan, focus on Alibaba\" data-tweet=\"$AABA $AABA $YAHOY - Susquehanna to Altaba: Cut bait on Yahoo Japan, focus on Alibaba https://seekingalpha.com/news/3368991-susquehanna-to-altaba-cut-bait-on-yahoo-japan-focus-on-alibaba?source=tweet\" data-url=\"https://seekingalpha.com/news/3368991-susquehanna-to-altaba-cut-bait-on-yahoo-japan-focus-on-alibaba\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368982\" data-ts=\"1531235887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGNX\" target=\"_blank\">RGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368982-regenxbio-adds-to-up-move-shares-ahead-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REGENXBIO adds to up move, shares ahead 3%</a></h4><ul><li>REGENXBIO (<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='green'>+2.9%</font>) is up on below-average volume. Shares have more than tripled since early April when Novartis <a href=\"https://seekingalpha.com/news/3344285-novartis-buy-avexis-8_7b\" target=\"_blank\">announced </a>its $8.7B takeout of AveXis. Money flow into gene therapy stocks has ramped up since then as investors expect more M&amp;A activity in the space.</li><li>Chardan analyst Gbola Amusa is along for the ride, raising his price target to $130 (55% upside) citing the company's leadership in AAV-based gene therapy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368982\" data-linked=\"REGENXBIO adds to up move, shares ahead 3%\" data-tweet=\"$RGNX - REGENXBIO adds to up move, shares ahead 3% https://seekingalpha.com/news/3368982-regenxbio-adds-to-up-move-shares-ahead-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3368982-regenxbio-adds-to-up-move-shares-ahead-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368981\" data-ts=\"1531235352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAK\" target=\"_blank\">BAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368981-report-lyondellbasell-odebrecht-to-seal-braskem-deal-mid-october\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: LyondellBasell, Odebrecht to seal Braskem deal by mid-October</a></h4><ul>     <li>Odebrecht is <a href=\"https://www.reuters.com/article/us-braskem-lyondell/odebrecht-lyondellbasell-to-seal-braskem-deal-by-mid-october-paper-idUSKBN1K01E7\" target=\"_blank\">set to agree on the sale</a> of its controlling stake in petrochemical company Braskem (<a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+3.8%</font>) to LyondellBasell Industries (<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a> <font color='green'>+0.3%</font>) by the middle of October, Brazilian newspaper <em>Valor Econ&ocirc;mico</em> reports.</li>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-0.1%</font>) will decide by theb whether to include its own stake in BAK in the deal, clearing the way for the transaction to be submitted to regulators, according to the report.</li>     <li>Odebrecht currently owns 50.1% of BAK's voting capital, while PBR holds 47%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368981\" data-linked=\"Report: LyondellBasell, Odebrecht to seal Braskem deal by mid-October\" data-tweet=\"$BAK $BAK $LYB - Report: LyondellBasell, Odebrecht to seal Braskem deal by mid-October https://seekingalpha.com/news/3368981-report-lyondellbasell-odebrecht-to-seal-braskem-deal-mid-october?source=tweet\" data-url=\"https://seekingalpha.com/news/3368981-report-lyondellbasell-odebrecht-to-seal-braskem-deal-mid-october\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368980\" data-ts=\"1531235333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTSL\" target=\"_blank\">MTSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368980-mer-telemanagementplus-163-among-nasdaq-top-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MER Telemanagement +163%, among Nasdaq top gainers</a></h4><ul>   <li>Israeli nanocap firm MER Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a>) is <font color='green'>up 163%</font> today, with Nasdaq volume spiking to 40 times normal after just a few hours of trading.</li>    <li>It's not clear what the catalyst for the big move is, if any. The company recently <a href=\"https://finance.yahoo.com/news/mts-submits-plan-nasdaq-regain-104400981.html\" target=\"_blank\">submitted a plan</a> to Nasdaq to regain compliance with a listing rule calling for minimum stockholders' equity of $2.5M.</li>    <li>That plan calls for cost-cutting measures, including reducing personnel, along with an institutional investor putting in $1.5M in return for issuance of a new class of convertible preferred stock.</li>    <li>Short interest had apparently increased over recent weeks to over 100,000 shares from about 80,000 shares short in the middle of June.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368980\" data-linked=\"MER Telemanagement +163%, among Nasdaq top gainers\" data-tweet=\"$MTSL - MER Telemanagement +163%, among Nasdaq top gainers https://seekingalpha.com/news/3368980-mer-telemanagementplus-163-among-nasdaq-top-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3368980-mer-telemanagementplus-163-among-nasdaq-top-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368979\" data-ts=\"1531234973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368979-cernerminus-4_4-on-evercore-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cerner -4.4% on Evercore downgrade</a></h4><ul><li>        Evercore ISI <a href=\"https://www.streetinsider.com/Analyst+Comments/Evercore+ISI+Downgrades+Cerner+%28CERN%29+to+Underperform/14384207.html\" target=\"_blank\">downgrades</a> Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) from Inline to Underperform.</li><li>               Price target drops from $57 to $55, a nearly 14% downside to yesterday&rsquo;s close.&nbsp;</li><li>               Cerner shares are&nbsp;<font color='red'>down 4.4%</font>&nbsp;to $60.88. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368979\" data-linked=\"Cerner -4.4% on Evercore downgrade\" data-tweet=\"$CERN - Cerner -4.4% on Evercore downgrade https://seekingalpha.com/news/3368979-cernerminus-4_4-on-evercore-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368979-cernerminus-4_4-on-evercore-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368977\" data-ts=\"1531234849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCX\" target=\"_blank\">OCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368977-healthcare-top-5-gainers-losers-of-11-00-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/INSP' title='Inspire Medical Systems, Inc.'>INSP</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368977\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/10/2018)\" data-tweet=\"$OCX $OCX $MNOV - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/10/2018) https://seekingalpha.com/news/3368977-healthcare-top-5-gainers-losers-of-11-00-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368977-healthcare-top-5-gainers-losers-of-11-00-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368975\" data-ts=\"1531234691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368975-hospital-operators-in-green\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital operators in the green</a></h4><ul><li>Hospital operators are all in the green this morning. Leaders HCA (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+0.3%</font>) and Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='green'>+0.5%</font>) kick off earnings season with their Q2 reports on July 25 and August 1, respectively.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='green'>+1.9%</font>)(<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+2.9%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='green'>+2.1%</font>)(<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+1.8%</font>)(<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+0.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368975\" data-linked=\"Hospital operators in the green\" data-tweet=\"$HCA $HCA $HUM - Hospital operators in the green https://seekingalpha.com/news/3368975-hospital-operators-in-green?source=tweet\" data-url=\"https://seekingalpha.com/news/3368975-hospital-operators-in-green\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368972\" data-ts=\"1531234328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBB\" target=\"_blank\">CBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368972-cincinnati-bellminus-7_5-ubs-cuts-outlook-on-ht-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cincinnati Bell -7.5% as UBS cuts outlook on HT purchase</a></h4><ul>   <li>Cincinnati Bell (NYSE:<a href='https://seekingalpha.com/symbol/CBB' title='Cincinnati Bell Inc.'>CBB</a>) has <font color='red'>slid 7.5%</font> amid a UBS downgrade to Neutral on concerns about the company's recently closed acquisition of Hawaiian Telcom.</li>    <li>In the near term, capital allocation is likely to focus on investment and deleveraging rather than shareholder returns, analyst Batya Levi writes. As for the longer term, Hawaiian Telcom results imply a lower contribution than expected. (h/t Bloomberg)</li>    <li>UBS reduces its price target to $18 from $22; shares are down to $16 today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368972\" data-linked=\"Cincinnati Bell -7.5% as UBS cuts outlook on HT purchase\" data-tweet=\"$CBB - Cincinnati Bell -7.5% as UBS cuts outlook on HT purchase https://seekingalpha.com/news/3368972-cincinnati-bellminus-7_5-ubs-cuts-outlook-on-ht-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3368972-cincinnati-bellminus-7_5-ubs-cuts-outlook-on-ht-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368968\" data-ts=\"1531233950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KDP\" target=\"_blank\">KDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368968-time-to-talk-keurig-dr-pepper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time to talk about Keurig Dr Pepper</a></h4><ul> <li>Keurig Dr Pepper (NYSE:<a href='https://seekingalpha.com/symbol/KDP' title='Keurig Dr Pepper Inc'>KDP</a>) opened for trading at $20.50 today and then bubbled up to as high as $21.08 before settling back to $20.91.</li> <li>There's already some buzz over what moves the new beverage company will pull off as it integrates complentary businesses. Wells Fargo analyst Bonnie Herzog sees a sale of the company's Body Armour stake to Coca-Cola (NYSE:<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a>) as a possibility.</li> <li>\"We don't think the new Keurig Dr. Pepper management team is interested in maintaining minority stakes (such as those Dr. Pepper undertook with its allied brands),\" writes Herzog. \"As such, we think there's a good chance BODYARMOR could seek out a new partner/owner and we think Coca-Cola would be very interested in the brand given its success (with BODYARMOR's retail sales over the last 52-weeks of $263 million in the Sports Drink category per Nielsen, up 84% y/y). We think Coca-Cola would position BODYARMOR as a premium, isotonic brand above Powerade,\" she adds.</li><li>Investors have a bit of a clean slate on Keurig Dr Pepper on day one of trading as investment firms aren't on record yet with their ratings and subsequent defenses.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3368766-meet-keurig-dr-pepper\" target=\"_blank\">Meet Keurig Dr Pepper</a> (July 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368968\" data-linked=\"Time to talk about Keurig Dr Pepper\" data-tweet=\"$KDP $KDP $KO - Time to talk about Keurig Dr Pepper https://seekingalpha.com/news/3368968-time-to-talk-keurig-dr-pepper?source=tweet\" data-url=\"https://seekingalpha.com/news/3368968-time-to-talk-keurig-dr-pepper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368959\" data-ts=\"1531233935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368959-biogen-gives-up-ban2401-stoked-gain-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen gives up more BAN2401-stoked gain, down 4%</a></h4><ul><li>Profit-taking in Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-3.7%</font>) continues on average volume. Shares have retraced more than&nbsp;<font color='red'>7%</font>&nbsp;since touching $367.89 on July 6, although still up&nbsp;<font color='green'>14%&nbsp;</font>since July 5.</li><li>Buying surged after the company reported positive 18-month data from a mid-stage study of BAN2401 in patients with early Alzheimer's disease, the same study that failed to demonstrate a treatment effect at month 12.</li><li>Baird's Brian Skorney is the latest analyst to question the robustness of the data. He downgraded the stock to Neutral with a $323 (5% downside risk) price target citing the ambiguous nature of the results. He wants to see specific data that support the relationship between drug-induced reductions in amyloid with slowing clinical progression, adding that ADCOMS is not an externally validated endpoint and \"we haven't seen any standard cognitive measures yet.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368369-leerinks-porges-board-biogens-positive-trial-results-alzheimers-candidate-ban2401\" target=\"_blank\">Leerink's Porges not on board with Biogen's positive trial results for Alzheimer's candidate BAN2401</a> (July 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368260-biogen-plus-6-percent-alzheimers-drug-succeeds-trial\" target=\"_blank\">Biogen +6% after Alzheimer's drug succeeds in trial</a> (July 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3319594-biogens-alzheimers-candidate-ban2401-flunks-mid-stage-study\" target=\"_blank\">Biogen's Alzheimer's candidate BAN2401 flunks mid-stage study</a> (Dec. 21, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368959\" data-linked=\"Biogen gives up more BAN2401-stoked gain, down 4%\" data-tweet=\"$BIIB - Biogen gives up more BAN2401-stoked gain, down 4% https://seekingalpha.com/news/3368959-biogen-gives-up-ban2401-stoked-gain-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3368959-biogen-gives-up-ban2401-stoked-gain-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368965\" data-ts=\"1531233820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLP\" target=\"_blank\">TLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368965-arclight-offers-to-buy-transmontaigne-partners-for-38-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcLight offers to buy TransMontaigne Partners for $38/share</a></h4><ul>     <li>Transmontaigne Partners (<a href='https://seekingalpha.com/symbol/TLP' title='TransMontaigne Partners, L.P.'>TLP</a> <font color='green'>+3.8%</font>) shoots higher after ArcLight Energy Partners <a href=\"https://seekingalpha.com/pr/17212048-arclight-makes-offer-acquire-transmontaigne-partners-l-p\" target=\"_blank\">offers to acquire</a> the company for $38/share in cash.</li>     <li>TLP cautions that a definitive agreement would be subject to various contingencies including the approval of TLP's conflicts committee, the general partner and a majority of unitholders.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368965\" data-linked=\"ArcLight offers to buy TransMontaigne Partners for $38/share\" data-tweet=\"$TLP - ArcLight offers to buy TransMontaigne Partners for $38/share https://seekingalpha.com/news/3368965-arclight-offers-to-buy-transmontaigne-partners-for-38-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3368965-arclight-offers-to-buy-transmontaigne-partners-for-38-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368964\" data-ts=\"1531233686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368964-pareteum-expects-q2-revenue-of-least-5_75m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum expects Q2 revenue of at least $5.75M</a></h4><ul>     <li>Pareteum (<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='red'>-2%</font>) expects to report Q2 revenues of at least $5.75M (+78% Y/Y) vs. a consensus of $4.75M.</li>     <li>Connections rose to ~2,713,600 (+225% Y/Y) as of June 30, 2018.</li>     <li>The company raised revenue outlook to 80% (Y/Y) for 2018.</li>     <li>Pareteum's Q2 earnings and results update call is expected to be held during the week of Aug. 6, 2018.</li><li><a href=\"https://seekingalpha.com/pr/17211579-pareteum-expects-second-quarter-2018-revenue-least-5_75-million\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3368964\" data-linked=\"Pareteum expects Q2 revenue of at least $5.75M\" data-tweet=\"$TEUM - Pareteum expects Q2 revenue of at least $5.75M https://seekingalpha.com/news/3368964-pareteum-expects-q2-revenue-of-least-5_75m?source=tweet\" data-url=\"https://seekingalpha.com/news/3368964-pareteum-expects-q2-revenue-of-least-5_75m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368951\" data-ts=\"1531233361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCDGF\" target=\"_blank\">OCDGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368951-ocado-group-up-3-post-h1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocado Group up 3% post H1 results</a></h4><ul><li>Ocado Group (<a href='https://seekingalpha.com/symbol/OCDGF' title='Ocado Group PLC'>OTCPK:OCDGF</a> <font color='green'>+3.2%</font>) reported H1 revenue growth of 12.1% Y/Y to &pound;799.99M reflecting increase in the average number of orders per week and fees earned from clients.</li><li>Overall gross margin&nbsp;<font color='red'>declined by 50 bps</font>&nbsp;to 34.23%, operating margin&nbsp;<font color='red'>declined by 202 bps</font>&nbsp;to -0.35% and EBITDA margin<font color='red'> declined by 147 bps</font>&nbsp;to 4.9%.</li><li>Retail Segment results: Revenue &pound;736.6M (+11.7% Y/Y) with orders per week of 291K (+11.9% Y/Y) and average order size of &pound;108.18 (-0.2% Y/Y); gross margin&nbsp;<font color='red'>declined by 76 bps</font>&nbsp;to 28.6% and EBITDA margin&nbsp;<font color='red'>declined by 68 bps</font>&nbsp;to 6.25.</li><li>Solutions Segment results: Revenue &pound;63.3M (+16.8% Y/Y) and EBITDA margin&nbsp;<font color='red'>declined by 390 bps</font>&nbsp;to -3.16%.</li><li>Active customers were 679K an increase of 12.8% Y/Y.</li><li>Company had cash and equivalents of &pound;447.6M at the end of H1.</li><li>Company signed three international partnerships with with Sobeys, ICA and Kroger to develop the Ocado Smart Platform in&nbsp;Canada,&nbsp;Sweden&nbsp;and&nbsp;the United States&nbsp;respectively.</li><li>FY18 Outlook: Retail business revenue growth between 10-15% and Capex ~&pound;210M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368850-ocado-group-reports-1h-results\" target=\"_blank\">Ocado Group reports 1H results</a> (July 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368951\" data-linked=\"Ocado Group up 3% post H1 results\" data-tweet=\"$OCDGF $OCDDY - Ocado Group up 3% post H1 results https://seekingalpha.com/news/3368951-ocado-group-up-3-post-h1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3368951-ocado-group-up-3-post-h1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368958\" data-ts=\"1531233344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORM\" target=\"_blank\">FORM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368958-b-riley-formfactor-nearing-growth-objectives-near-term-dram-cloudy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B. Riley: FormFactor nearing growth objectives, near-term DRAM cloudy</a></h4><ul><li>        B. Riley comments on FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) following a meeting with management and sees long-term EPS of over $1.50 as a possibility in the next few years.</li><li>               The firm sees two issues clouding near-term visibility: a Korean customer&rsquo;s 1Y DRAM ramp and Intel&rsquo;s unexpected CEO transition, which clouds the outlook for the next 14nm architecture refresh and potentially 10nm ramp timing. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>        But B. Riley says these are now well known and advises investors to look for a FormFactor position on any market or post-results volatility. Valuation is 12.4x and 9.2x CY18 and CY19 EPS.</li><li>               Price target: $19.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               FormFactor shares are&nbsp;<font color='red'>down 5.8%</font>&nbsp;to $13.90.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368958\" data-linked=\"B. Riley: FormFactor nearing growth objectives, near-term DRAM cloudy\" data-tweet=\"$FORM - B. Riley: FormFactor nearing growth objectives, near-term DRAM cloudy https://seekingalpha.com/news/3368958-b-riley-formfactor-nearing-growth-objectives-near-term-dram-cloudy?source=tweet\" data-url=\"https://seekingalpha.com/news/3368958-b-riley-formfactor-nearing-growth-objectives-near-term-dram-cloudy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368953\" data-ts=\"1531233023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHK\" target=\"_blank\">MHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368953-mohawk-industries-lower-on-report-of-potential-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mohawk Industries lower on report of potential downgrade</a></h4><ul> <li>Mohawk Industries (NYSE:<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries Inc.'>MHK</a>) is <font color='red'>down 1.33%</font> after the stock is reported by Bloomberg to have earned a \"red flag\" rating from Herb Greenberg's Pacific Square Research.</li> <li>Shares of Mohawk are already down 21% YTD.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3368953\" data-linked=\"Mohawk Industries lower on report of potential downgrade\" data-tweet=\"$MHK - Mohawk Industries lower on report of potential downgrade https://seekingalpha.com/news/3368953-mohawk-industries-lower-on-report-of-potential-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368953-mohawk-industries-lower-on-report-of-potential-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368947\" data-ts=\"1531232593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368947-global-blood-down-5-on-bearish-favus-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood down 5% on bearish Favus report</a></h4><ul><li>Global Blood Therapeutics (<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='red'>-5.1%</font>) is down in early trade on below-average volume in apparent response to a bearish report from <a href=\"http://www.favusinstitutionalresearch.com/\" target=\"_blank\">Favus Institutional Research</a>. Details are scarce, however.</li><li>Shares have sold off&nbsp;<font color='red'>18%</font>&nbsp;since touching $50.20 on June 28.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368947\" data-linked=\"Global Blood down 5% on bearish Favus report\" data-tweet=\"$GBT - Global Blood down 5% on bearish Favus report https://seekingalpha.com/news/3368947-global-blood-down-5-on-bearish-favus-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3368947-global-blood-down-5-on-bearish-favus-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368943\" data-ts=\"1531232171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSTI\" target=\"_blank\">SSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368943-stellar-run-for-shotspotter-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stellar run for ShotSpotter continues</a></h4><ul> <li>Shares of ShotSpotter (NASDAQ:<a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter'>SSTI</a>) race 6.70% higher after Imperial Capital lifts its price target on the gunshot detecting company to $50.</li> <li>ShotSpotter traded at a new post-IPO high of $43.67 earlier this morning. The ShotSpotter IPO priced at $11 on June 7, 2017.</li><li>There's some good discussion on Seeking Alpha contributor Shareholders Unite's <a href=\"https://seekingalpha.com/article/4186201-shotspotter-unstoppable\" target=\"_blank\">article</a> on whether or not it's too late to buy into the rally.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3368943\" data-linked=\"Stellar run for ShotSpotter continues\" data-tweet=\"$SSTI - Stellar run for ShotSpotter continues https://seekingalpha.com/news/3368943-stellar-run-for-shotspotter-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3368943-stellar-run-for-shotspotter-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368942\" data-ts=\"1531232142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISR\" target=\"_blank\">ISR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368942-isoray-announces-stock-offering-shares-down-41\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IsoRay announces stock offering; shares down 41%</a></h4><ul><li>Thinly traded nano cap IsoRay (<a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a> <font color='red'>-40.6%</font>) is down on a 31x surge in volume, giving up a sizeable chunk of yesterday's FDA clearance-stoked&nbsp;<font color='green'>143%</font>&nbsp;gain.</li><li>After the close yesterday, it <a href=\"https://seekingalpha.com/pr/17211019-isoray-announces-8_25-million-registered-direct-offering\" target=\"_blank\">announced </a>a direct offering of 11M common shares at $0.75 per share to institutional investors who will also receive warrants to purchase up to 5.5M shares at $0.75.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368769-isoray-plus-143-percent-fda-clears-brachytherapy-technology\" target=\"_blank\">IsoRay +143% after FDA clears brachytherapy technology</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368942\" data-linked=\"IsoRay announces stock offering; shares down 41%\" data-tweet=\"$ISR - IsoRay announces stock offering; shares down 41% https://seekingalpha.com/news/3368942-isoray-announces-stock-offering-shares-down-41?source=tweet\" data-url=\"https://seekingalpha.com/news/3368942-isoray-announces-stock-offering-shares-down-41\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368940\" data-ts=\"1531231775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIL\" target=\"_blank\">GIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368940-hedgeye-adds-gilead-activewear-to-best-ideas-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye adds Gilead Activewear to best ideas list</a></h4><ul> <li>Hedgeye adds Gildan Activewear (<a href='https://seekingalpha.com/symbol/GIL' title='Gildan Activewear Inc.'>GIL</a> <font color='green'>+0.7%</font>) to its best idea long list.</li> <li>Shares of Gilead Activewear are down 14.30% YTD and trade at about 13.5X the consensus FY19 EPS estimate.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3368940\" data-linked=\"Hedgeye adds Gilead Activewear to best ideas list\" data-tweet=\"$GIL - Hedgeye adds Gilead Activewear to best ideas list https://seekingalpha.com/news/3368940-hedgeye-adds-gilead-activewear-to-best-ideas-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3368940-hedgeye-adds-gilead-activewear-to-best-ideas-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368939\" data-ts=\"1531231729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368939-endeavour-silver-reports-q2-gains-in-silver-gold-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endeavour Silver reports Q2 gains in silver, gold production</a></h4><ul>     <li>Endeavour Silver (<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='red'>-2.4%</font>) releases <a href=\"https://seekingalpha.com/pr/17211190-endeavour-silver-produces-1355-895-oz-silver-13674-oz-gold-2_4-million-oz-silver-equivalents\" target=\"_blank\">Q2 production results</a> for its three Mexican mines, showing an uptick in both silver and gold production.</li>     <li>EXK says Q2 silver production rose 19% Y/Y to ~1.35M oz., primarily due to higher output and ore grades at the El Cubo mine in Mexico, and gold production gained 5% to 13.6K oz., resulting in silver equiv. production of 2.4M oz.</li>     <li>For H1, EXK produced 2.71M oz. of silver and 26.9K oz. of gold, representing respective Y/Y gains of 22% and 8%, for silver equiv. oz. of 4.72M, up 16% from the year-ago period.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368939\" data-linked=\"Endeavour Silver reports Q2 gains in silver, gold production\" data-tweet=\"$EXK - Endeavour Silver reports Q2 gains in silver, gold production https://seekingalpha.com/news/3368939-endeavour-silver-reports-q2-gains-in-silver-gold-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3368939-endeavour-silver-reports-q2-gains-in-silver-gold-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368931\" data-ts=\"1531231238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368931-leading-boston-hospital-implants-reshape-balloon-shares-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leading Boston hospital implants ReShape Balloon; shares up 12%</a></h4><ul><li>Thinly traded nano cap ReShape Lifesciences (<a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a> <font color='green'>+11.9%</font>) is up a healthy 31x surge in volume on the heels of is <a href=\"https://seekingalpha.com/pr/17211446-reshape-lifesciences-expands-intra-gastric-balloon-business-include-brigham-womens-hospital\" target=\"_blank\">announcement </a>that Boston's Brigham and Women's Hospital has implanted its first ReShape Balloon for the treatment obesity.</li><li>The <a href=\"https://www.reshapelifesciences.com/reshape-gastric-balloon/\" target=\"_blank\">balloon </a>is placed in the stomach, then filled with saline, giving the patient the feeling of fullness, reducing food intake and promoting weight loss.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368931\" data-linked=\"Leading Boston hospital implants ReShape Balloon; shares up 12%\" data-tweet=\"$RSLS - Leading Boston hospital implants ReShape Balloon; shares up 12% https://seekingalpha.com/news/3368931-leading-boston-hospital-implants-reshape-balloon-shares-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3368931-leading-boston-hospital-implants-reshape-balloon-shares-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368926\" data-ts=\"1531231067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANCUF\" target=\"_blank\">ANCUF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368926-alimentation-couche-tard-up-9_2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alimentation Couche-Tard up 9.2% post Q4 results</a></h4><ul><li>Alimentation Couche-Tard (<a href='https://seekingalpha.com/symbol/ANCUF' title='Alimentation Couche-Tard Inc.'>OTCPK:ANCUF</a> <font color='green'>+9.2%</font>) <u><a href=\"https://seekingalpha.com/pr/17210980-alimentation-couche-tard-announces-results-fourth-quarter-fiscal-year-2018\" target=\"_blank\">reports Q4</a></u>&nbsp;revenue growth of 41.5% Y/Y to $13.6B.</li><li>Total merchandise and service revenues of $3.2B (+25% Y/Y), Same-store merchandise revenues increased by 1.8% in the&nbsp;U.S., 4.3% in&nbsp;Europe&nbsp;and by 3.6% in&nbsp;Canada.</li><li>Since the acquisition, CST sites same-store merchandise revenues grew both in the&nbsp;U.S&nbsp;and in&nbsp;Canada.</li><li>Merchandise and service gross margin&nbsp;<font color='green'>increased 30 bps</font>&nbsp;in the&nbsp;U.S. to 33.6%, it remained stable in&nbsp;Europe&nbsp;at 44% and, in&nbsp;Canada, it&nbsp;<font color='red'>decreased 30 bps</font>&nbsp;to 34.4%.</li><li>Total road transportation fuel volumes grew by&nbsp;<font color='green'>33.8%</font>; Same-store road transportation fuel volumes decreased by<font color='red'> 0.1%</font>&nbsp;in the&nbsp;U.S.&nbsp;and by&nbsp;<font color='red'>2.9%&nbsp;</font>in&nbsp;Canada, while same-store volumes increased by&nbsp;<font color='green'>0.1%</font>&nbsp;in&nbsp;Europe.</li><li>Current annual synergies run rate related to the CST integration reached ~$153M.</li><li>Adjusted leverage ratio improved to 3.13:1.</li><li>Road transportation fuel gross margin increased by US 1.82&cent; per gallon in the&nbsp;U.S.&nbsp;to US 17.29&cent; per gallon, by US 0.89&cent; per litre in&nbsp;Europe, to US 8.72&cent; per litre and by CA 1.39&cent; per litre in&nbsp;Canada, to CA 9.44&cent; per litre.</li><li>Increase of CA 1&cent; of the quarterly dividend, a growth of 11.1%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368760-alimentation-couche-tard-reports-q4-results\" target=\"_blank\">Alimentation Couche-Tard reports Q4 results</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368926\" data-linked=\"Alimentation Couche-Tard up 9.2% post Q4 results\" data-tweet=\"$ANCUF - Alimentation Couche-Tard up 9.2% post Q4 results https://seekingalpha.com/news/3368926-alimentation-couche-tard-up-9_2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3368926-alimentation-couche-tard-up-9_2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368930\" data-ts=\"1531230828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368930-stmicroelectronics-acquires-touchgfx-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STMicroelectronics acquires TouchGFX company</a></h4><ul><li>        STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) <a href=\"https://seekingalpha.com/pr/17211860-stmicroelectronics-acquires-graphical-user-interface-software-specialist-draupner-graphic\" target=\"_blank\">acquires</a> software specialist Draupner Graphics for undisclosed terms.</li><li>               Draupner develops the software framework TouchGFX, which offers graphics and animations for embedded GUI with minimal resource and power requirements. &nbsp;&nbsp;</li><li>               Several STMicroelectronics products from its STM32 MCU family already support TouchGFX.&nbsp;</li><li>               TouchGFX <a href=\"https://touchgfx.com/about/who-we-are/\" target=\"_blank\">was invented</a> in 2009, and Draupner Graphics was founded in 2014 as a spin-off to commercialize the product further.&nbsp;</li><li>               STM shares are<font color='green'> up 1%</font>&nbsp;to $22.94.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368930\" data-linked=\"STMicroelectronics acquires TouchGFX company\" data-tweet=\"$STM - STMicroelectronics acquires TouchGFX company https://seekingalpha.com/news/3368930-stmicroelectronics-acquires-touchgfx-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3368930-stmicroelectronics-acquires-touchgfx-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368919\" data-ts=\"1531229766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLIC\" target=\"_blank\">KLIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368919-kulicke-and-soffa-adds-100m-to-share-repurchase-authorization\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kulicke and Soffa adds $100M to share repurchase authorization</a></h4><ul><li>        Kulicke and Soffa&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/KLIC' title='Kulicke and Soffa Industries, Inc.'>KLIC</a>) board <a href=\"https://seekingalpha.com/pr/17211885-kulicke-and-soffa-increases-repurchase-authorization-100m\" target=\"_blank\">increases</a> its share repurchase authorization by $100M.</li><li>               Kulicke and Soffa shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;to $25.59. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368919\" data-linked=\"Kulicke and Soffa adds $100M to share repurchase authorization\" data-tweet=\"$KLIC - Kulicke and Soffa adds $100M to share repurchase authorization https://seekingalpha.com/news/3368919-kulicke-and-soffa-adds-100m-to-share-repurchase-authorization?source=tweet\" data-url=\"https://seekingalpha.com/news/3368919-kulicke-and-soffa-adds-100m-to-share-repurchase-authorization\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368913\" data-ts=\"1531229348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368913-raymond-james-warns-on-irobot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James warns on iRobot</a></h4><ul> <li>Shares of iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) head lower after Raymond James downgrades on valuation and competition concerns.</li> <li>Analyst Brian Gesuale takes the Roomba maker to a Market Perform rating from Outperform after taking in the 90-day rally of 22%.</li> <li>IRBT <font color='red'>-4.59%</font> premarket to $77.20.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368913\" data-linked=\"Raymond James warns on iRobot\" data-tweet=\"$IRBT - Raymond James warns on iRobot https://seekingalpha.com/news/3368913-raymond-james-warns-on-irobot?source=tweet\" data-url=\"https://seekingalpha.com/news/3368913-raymond-james-warns-on-irobot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368911\" data-ts=\"1531229248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMMT\" target=\"_blank\">SMMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368911-summit-nabs-4_5m-grant-to-support-development-of-new-antibiotics-shares-up-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit nabs $4.5M grant to support development of new antibiotics; shares up 11% premarket</a></h4><ul><li>Thinly traded nano cap Summit Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17211261-summit-awarded-4_5-million-grant-carb-x-development-new-mechanism-gonorrhoea-antibiotics\" target=\"_blank\">announcement </a>that it has been award a $4.5M grant from a public/private partnership called CARB-X to support the development of new antibiotics to treat gonorrhoea.</li><li>$2M in initial funding will used to support the selection of a preclinical candidate, expected in H2. The remaining $2.5M will be awarded upon the achievement of certain development milestones.</li><li>The total amount should be sufficient to fund development through Phase 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368911\" data-linked=\"Summit nabs $4.5M grant to support development of new antibiotics; shares up 11% premarket\" data-tweet=\"$SMMT - Summit nabs $4.5M grant to support development of new antibiotics; shares up 11% premarket https://seekingalpha.com/news/3368911-summit-nabs-4_5m-grant-to-support-development-of-new-antibiotics-shares-up-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3368911-summit-nabs-4_5m-grant-to-support-development-of-new-antibiotics-shares-up-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368909\" data-ts=\"1531229148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISR\" target=\"_blank\">ISR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368909-premarket-losers-of-9-05-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (07/10/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a>&nbsp;<font color='red'>-36%</font>&nbsp;after FDA <a href=\"https://seekingalpha.com/news/3368769-isoray-plus-143-percent-fda-clears-brachytherapy-technology\" target=\"_blank\">clears</a> brachytherapy technology.</li>     <li><a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a>&nbsp;<font color='red'>-15%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AQXP' title='Aquinox Pharmaceuticals, Inc.'>AQXP</a>&nbsp;<font color='red'>-9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/TKC' title='Turkcell Iletisim Hizmetleri A.S.'>TKC</a>&nbsp;<font color='red'>-7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>&nbsp;<font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368909\" data-linked=\"Premarket Losers as of 9:05 am (07/10/2018)\" data-tweet=\"$ISR $ISR $STAF - Premarket Losers as of 9:05 am (07/10/2018) https://seekingalpha.com/news/3368909-premarket-losers-of-9-05-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368909-premarket-losers-of-9-05-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368906\" data-ts=\"1531228911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAEX\" target=\"_blank\">SAEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368906-saexplorationplus-15-after-upsize-of-credit-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAExploration +15% after upsize of credit facility</a></h4><ul>     <li>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>)&nbsp;<font color='green'>+15.3%</font> premarket after announcing an upsize of its credit facility to increase the lenders&rsquo; maximum commitment to $30M.</li><li>SAE alos says it plans to redeem the remaining $1.86M outstanding principal amount of its original $150M of 10% senior secured notes due 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368906\" data-linked=\"SAExploration +15% after upsize of credit facility\" data-tweet=\"$SAEX - SAExploration +15% after upsize of credit facility https://seekingalpha.com/news/3368906-saexplorationplus-15-after-upsize-of-credit-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/3368906-saexplorationplus-15-after-upsize-of-credit-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368902\" data-ts=\"1531228479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLIN\" target=\"_blank\">BLIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368902-bridgeline-digitalplus-134-on-bank-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bridgeline Digital +134% on bank partnership</a></h4><ul><li>        Bridgeline Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a>)&nbsp;<font color='green'>soars 134%</font>&nbsp;premarket to $3.06 as the company <a href=\"https://seekingalpha.com/pr/17211230-bridgeline-unbound-digital-experience-platform-power-bank-s-customer-experience\" target=\"_blank\">announces</a> a partnership with a full-service bank to power its digital presence.</li><li>               The engagement is a three-year SaaS subscription to Bridgeline&rsquo;s Unbound Digital Experience Platform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368902\" data-linked=\"Bridgeline Digital +134% on bank partnership\" data-tweet=\"$BLIN - Bridgeline Digital +134% on bank partnership https://seekingalpha.com/news/3368902-bridgeline-digitalplus-134-on-bank-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3368902-bridgeline-digitalplus-134-on-bank-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368901\" data-ts=\"1531228457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLIN\" target=\"_blank\">BLIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368901-premarket-gainers-of-9-05-07-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/10/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+131%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17211230-bridgeline-unbound-digital-experience-platform-power-bank-s-customer-experience\" target=\"_blank\">partnering</a> with a full-service bank to power their digital presence.</li>     <li><a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a> <font color='green'>+46%</font>&nbsp;on better-than-expected <a href=\"https://seekingalpha.com/news/3368749-oncocyte-reports-better-expected-results-lung-cancer-liquid-biopsy-test-shares-56-percent\" target=\"_blank\">results</a> from lung cancer liquid biopsy test.</li>     <li><a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+15%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17210937-saexploration-announces-upsize-credit-facility-redemption-senior-notes\" target=\"_blank\">upsize</a> of credit facility and redemption of senior notes.</li>     <li><a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='green'>+15%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17211259-dropcar-partners-volvo-cars-manhattan\" target=\"_blank\">partners</a> with Volvo Cars Manhattan.</li>     <li><a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17211261-summit-awarded-4_5-million-grant-carb-x-development-new-mechanism-gonorrhoea-antibiotics\" target=\"_blank\">receiving</a>&nbsp;up to $4.5M grant.</li>     <li><a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a> <font color='green'>+12%</font>&nbsp;on the <a href=\"https://seekingalpha.com/pr/17211446-reshape-lifesciences-expands-intra-gastric-balloon-business-include-brigham-womens-hospital\" target=\"_blank\">successful</a> implant of the first ReShape Balloon at the Brigham and Women's Hospital in&nbsp;Boston.</li>     <li><a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+8%</font>&nbsp;on tailored clothing <a href=\"https://seekingalpha.com/news/3368808-differential-brands-robert-graham-signs-tailored-clothing-partnership-peerless\" target=\"_blank\">partnership</a> with Peerless.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368901\" data-linked=\"Premarket Gainers as of 9:05 am (07/10/2018)\" data-tweet=\"$BLIN $BLIN $OCX - Premarket Gainers as of 9:05 am (07/10/2018) https://seekingalpha.com/news/3368901-premarket-gainers-of-9-05-07-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368901-premarket-gainers-of-9-05-07-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368897\" data-ts=\"1531228183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368897-wynn-resorts-tracks-higher-after-stifel-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn Resorts tracks higher after Stifel upgrade</a></h4><ul> <li>Stifel upgrades Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) to a Buy rating after having the casino stock sitting on a Hold rating.</li> <li>The analyst team sees a stronger risk-reward profile on Wynn for investors with a long-term view.</li> <li>Shares of Wynn are perky off the ratings bump, <font color='green'>up 1.33%</font> in premarket trading to $162.26.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368897\" data-linked=\"Wynn Resorts tracks higher after Stifel upgrade\" data-tweet=\"$WYNN - Wynn Resorts tracks higher after Stifel upgrade https://seekingalpha.com/news/3368897-wynn-resorts-tracks-higher-after-stifel-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368897-wynn-resorts-tracks-higher-after-stifel-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368896\" data-ts=\"1531228133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368896-splunkminus-2-evercore-backs-away\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk -2% as Evercore backs away</a></h4><ul><li>        Evercore ISI downgrades Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) from Outperform to Inline with a $110 price target, a nearly 8% upside to yesterday&rsquo;s close.</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Splunk shares are&nbsp;<font color='red'>down 2%</font>&nbsp;premarket to $100.10.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368896\" data-linked=\"Splunk -2% as Evercore backs away\" data-tweet=\"$SPLK - Splunk -2% as Evercore backs away https://seekingalpha.com/news/3368896-splunkminus-2-evercore-backs-away?source=tweet\" data-url=\"https://seekingalpha.com/news/3368896-splunkminus-2-evercore-backs-away\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368894\" data-ts=\"1531227756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOXO\" target=\"_blank\">LOXO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368894-loxo-slips-3-premarket-on-planned-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loxo slips 3% premarket on planned stock offering</a></h4><ul><li>Loxo Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/LOXO' title='Loxo Oncology'>LOXO</a>) eases&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume. According to Bloomberg, it is planning an offering of 1.4M shares of common stock at $181 per share.</li><li>Yesterday's close was $186.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368894\" data-linked=\"Loxo slips 3% premarket on planned stock offering\" data-tweet=\"$LOXO - Loxo slips 3% premarket on planned stock offering https://seekingalpha.com/news/3368894-loxo-slips-3-premarket-on-planned-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3368894-loxo-slips-3-premarket-on-planned-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368889\" data-ts=\"1531227468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMDA\" target=\"_blank\">KMDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368889-chmp-on-board-design-of-late-stage-study-of-kamadas-inhaled-aat-for-aatd-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHMP on board with design of late-stage study of Kamada&#39;s inhaled AAT for AATD; shares up 4% premarket</a></h4><ul><li>Kamada Ltd. (NASDAQ:<a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd'>KMDA</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17211225-kamada-receives-positive-scientific-advice-european-medicines-agency-new-phase-3-study-design\" target=\"_blank\">announcement</a> that the European Medicines Agency's &#40;EMA&#41; advisory group CHMP has agreed with the overall design of its planned Phase 3 clinical trial evaluating its inhaled alpha-1 antitrypsin &#40;AAT&#41; therapy for the treatment of alpha-1 antitrypsin deficiency &#40;AATD&#41;.</li><li>Discussions with the FDA on the Phase 3 design in the U.S. are ongoing. It expects to submit an amended study protocol next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368889\" data-linked=\"CHMP on board with design of late-stage study of Kamada&#39;s inhaled AAT for AATD; shares up 4% premarket\" data-tweet=\"$KMDA - CHMP on board with design of late-stage study of Kamada&#39;s inhaled AAT for AATD; shares up 4% premarket https://seekingalpha.com/news/3368889-chmp-on-board-design-of-late-stage-study-of-kamadas-inhaled-aat-for-aatd-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3368889-chmp-on-board-design-of-late-stage-study-of-kamadas-inhaled-aat-for-aatd-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368888\" data-ts=\"1531227463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KHC\" target=\"_blank\">KHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368888-kraft-heinz-taking-bids-for-india-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kraft Heinz taking bids for India unit</a></h4><ul> <li>Blackstone and Carlyle are two of the firms in the <a href=\"https://economictimes.indiatimes.com/industry/cons-products/food/pe-funds-companies-in-race-to-acquire-kraft-heinz-indias-consumer-food-unit/articleshow/64925077.cms\" target=\"_blank\">hunt</a> for the consumer food division unit of Kraft Heinz (NASDAQ:<a href='https://seekingalpha.com/symbol/KHC' title='The Kraft Heinz Company'>KHC</a>) in India, reports <em>The Economic Times</em>.</li> <li>A deal could include the consumer healthcare business of Kraft in India as well.</li> <li>Kraft hopes to see bids of around $1B for the business.</li> <li>Shares of Kraft Heinz are <font color='green'>up 0.67%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368888\" data-linked=\"Kraft Heinz taking bids for India unit\" data-tweet=\"$KHC - Kraft Heinz taking bids for India unit https://seekingalpha.com/news/3368888-kraft-heinz-taking-bids-for-india-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3368888-kraft-heinz-taking-bids-for-india-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368878\" data-ts=\"1531226545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368878-vivus-up-15-premarket-on-positive-data-for-pah-candidate-viminus-0106\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus up 15% premarket on positive data for PAH candidate VI-0106</a></h4><ul><li>Nano cap Vivus (NASDAQ:<a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a>) is up&nbsp;<font color='green'>15%</font>&nbsp;premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17211287-vivus-announces-positive-results-phase-1-clinical-trial-viminus-0106\" target=\"_blank\">announcement </a>of positive data from a Phase 1 clinical trial evaluating VI-0106 in healthy volunteers.</li><li>The company says the results show that once-daily dosing may facilitate of the low tacrolimus concentrations needed for the treatment of pulmonary arterial hypertension &#40;PAH&#41; with minimal monitoring of drug levels.</li><li>Per the ongoing COMPERA registry study, the five-year survival rate for high-risk PAH patients is 22.8%. Also, data from three class 3/4 patients treated with VI-0106 under compassionate use status showed dramatically reduced hospitalization rates and improvements in functional class.</li><li>VI-0106 is a soft capsule formulation of tacrolimus (topical formulation is used to treat atopic dermatitis) being developed to treat PAH. The company plans to request Fast Track and Breakthrough Therapy designations in the U.S. for the indication in conjunction with its planned 505(b)(2) marketing application which allows the inclusion of data generated by others.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368878\" data-linked=\"Vivus up 15% premarket on positive data for PAH candidate VI-0106\" data-tweet=\"$VVUS - Vivus up 15% premarket on positive data for PAH candidate VI-0106 https://seekingalpha.com/news/3368878-vivus-up-15-premarket-on-positive-data-for-pah-candidate-viminus-0106?source=tweet\" data-url=\"https://seekingalpha.com/news/3368878-vivus-up-15-premarket-on-positive-data-for-pah-candidate-viminus-0106\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368870\" data-ts=\"1531225807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368870-bitcoin-bounce-fails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin bounce fails</a></h4><ul><li>Over the weekend and into Monday, Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) appeared poised to make a run at $7K after tumbling below $6K late last month. That bounce has been nixed in the past few hours, with the crypto retreating to $6.3K,&nbsp;<font color='red'>down 4.5%&nbsp;</font>for the day.</li><li>Ethereum (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>), and Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>) have all dipped by even higher percentages today.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>, <a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>, <a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>, <a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3368870\" data-linked=\"Bitcoin bounce fails\" data-tweet=\"$BTC-USD $BTC-USD $ETH-USD - Bitcoin bounce fails https://seekingalpha.com/news/3368870-bitcoin-bounce-fails?source=tweet\" data-url=\"https://seekingalpha.com/news/3368870-bitcoin-bounce-fails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368869\" data-ts=\"1531225566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368869-margin-pain-seen-for-nordstrom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margin pain seen for Nordstrom</a></h4><ul> <li>KeyBanc lowers Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) to Sector Weight from Overweight on a call tied to valuation concerns.</li> <li>The firm notes that the increase in Nordstrom's e-commerce business to a 25% penetration level creates margin headwinds as the mix of store sales drifts even lower in the future.</li> <li><a href=\"https://seekingalpha.com/article/4186253-nordstrom-downgrade-hold\" target=\"_blank\">Seeking Alpha contributor Siddharth</a> is also talking a similar theme on Nordstrom today. \"The company is factoring in virtually no growth in the next five years. The shift to e-commerce will only add shipping charges to the expense column and make it hard to expand margins,\" he notes.</li> <li>JWN <font color='red'>-1.10%</font> premarket to $52.93 vs. a 52-week trading range of $37.79 to $54.11.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368869\" data-linked=\"Margin pain seen for Nordstrom\" data-tweet=\"$JWN - Margin pain seen for Nordstrom https://seekingalpha.com/news/3368869-margin-pain-seen-for-nordstrom?source=tweet\" data-url=\"https://seekingalpha.com/news/3368869-margin-pain-seen-for-nordstrom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368865\" data-ts=\"1531224922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APLS\" target=\"_blank\">APLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368865-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Apellis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a>) initiated withy Outperform rating and $40 (97% upside) price target at Cowen and Company.</li><li>Krystal Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a>) initiated with Outperform rating and $29 (93% upside) price target at William Blair.</li><li>Rocket Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a>) initiated with Outperform rating and $32 (63% upside) price target at William Blair.</li><li>Verrica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a>) initiated with Buy rating and $24 (21% upside) price target at Jefferies. Initiated with Outperform rating and $35 priced target at Cowen. Initiated with Buy rating and $26 price target at BofA/Merrill Lynch.</li><li>MyoKardia (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a>) initiated with Buy rating and $71 (34% upside) price target at BofA/Merrill Lynch.</li><li>Quest Diagnostics (NYSE:<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a>) upgraded to Outperform with a $121 (9% upside) price target at Evercore ISI. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) downgraded to Neutral with a $323 (9% downside risk) price target at Baird. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) downgraded to Underperform with a $55 (14% downside risk) price target at Evercore ISI. Shares down&nbsp;<font color='red'>2%&nbsp;</font>premarket.</li><li>Glaukos (NYSE:<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a>) downgraded to Market Perform with a $44 (3% upside) price target at BMO.</li><li>Healthcare Trust (NYSE:<a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a>) downgraded to Neutral at MUFG.</li><li>Regulus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>) downgraded to Neutral with a $1 (178% upside) price target at Wedbush. Shares up&nbsp;<font color='green'>6%</font>&nbsp;premarket.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Neutral with a $67 (5% upside) price target at Evercore ISI. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) downgraded to Neutral at Piper Jaffray. Shares up&nbsp;<font color='green'>7%</font>&nbsp;premarket.</li><li>Wright Medical Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WMGI' title='Wright Medical Group, Inc.'>WMGI</a>) downgraded to Market Perform at BMO Capital Markets. Shares down&nbsp;<font color='red'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368865\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$APLS $APLS $KRYS - Premarket analyst action - healthcare https://seekingalpha.com/news/3368865-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3368865-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368864\" data-ts=\"1531224821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368864-keybanc-latest-to-buy-stitch-fix-story\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc the latest to buy Stitch Fix story</a></h4><ul> <li>The rally in Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) could keep on going as more Wall Street firms buy into the apparel upstart's business model.</li> <li>Today it's KeyBanc with an upgrade on Stitch Fix to Overweight to go along with a fresh price target of $38. The firm sees data-driven personalization as one of the strongest growth opportunities in the retail sector. The analyst team also point to the opportunity for Stitch Fix in the men's, plus sizes and kids categories.</li> <li>Shares of Stitch Fix are <font color='green'>up 3.79%</font> in premarket trading to $32.30. Over the last 90 days, SFIX is up 39%.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368864\" data-linked=\"KeyBanc the latest to buy Stitch Fix story\" data-tweet=\"$SFIX - KeyBanc the latest to buy Stitch Fix story https://seekingalpha.com/news/3368864-keybanc-latest-to-buy-stitch-fix-story?source=tweet\" data-url=\"https://seekingalpha.com/news/3368864-keybanc-latest-to-buy-stitch-fix-story\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368847\" data-ts=\"1531223440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368847-kb-home-jumps-4_4-after-susquehanna-upgrades-on-expansion-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home jumps 4.4% after Susquehanna upgrades on expansion outlook</a></h4><ul><li>KB Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>)&nbsp;<font color='green'>gains 4.4%</font>&nbsp;in premarket trading after Susquehanna analyst Jack Micenko upgrades the homebuilder to positive from neutral and raised his price target to $36 from $34, Bloomberg reports.</li><li>Micenko sees \"a clear and visible path\" to gross margin expansion and that he expects a rebound in community count and order growth into next year, he wrote in a note.</li><li>Meanwhile, Mizuho analyst Haendel St. Juste raised KBH's 2018 EPS estimate to $2.86 from $2.72, but cut price target to $28 from $33, citing EPS growth is likely to slow into next year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367064-kb-home-plus-5-percent-q2-earnings-top-estimates-amid-strong-housing-market\" target=\"_blank\">KB Home +5% after Q2 earnings top estimates amid strong housing market</a> (June 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368847\" data-linked=\"KB Home jumps 4.4% after Susquehanna upgrades on expansion outlook\" data-tweet=\"$KBH - KB Home jumps 4.4% after Susquehanna upgrades on expansion outlook https://seekingalpha.com/news/3368847-kb-home-jumps-4_4-after-susquehanna-upgrades-on-expansion-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3368847-kb-home-jumps-4_4-after-susquehanna-upgrades-on-expansion-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368845\" data-ts=\"1531223394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368845-suntrust-warns-on-ebay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust warns on eBay</a></h4><ul> <li>SunTrust <a href=\"https://www.cnbc.com/2018/07/10/stocks-making-the-biggest-moves-premarket-pep-ebay-pfe-wba-xrx--.html?__source=newsletter%7Cbreakingnews\" target=\"_blank\">warns</a> that eBay (NASDAQ:<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a>) will sees some headwinds after the Supreme Court ruling on e-commerce tax collection by individual states.</li> <li>The firm lowers its rating on eBay to Hold from Buy after factoring in the additional costs setting up over the next year.</li> <li>Shares of eBay are <font color='red'>down 1.61%</font> in premarket trading to $37.30 vs. a 52-week trading range of $33.94 to $46.99.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368845\" data-linked=\"SunTrust warns on eBay\" data-tweet=\"$EBAY - SunTrust warns on eBay https://seekingalpha.com/news/3368845-suntrust-warns-on-ebay?source=tweet\" data-url=\"https://seekingalpha.com/news/3368845-suntrust-warns-on-ebay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368832\" data-ts=\"1531222204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKP\" target=\"_blank\">CHKP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368832-btig-upgrades-check-point-software-18-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG upgrades Check Point Software with 18% upside</a></h4><ul><li>        BTIG <a href=\"https://www.streetinsider.com/Analyst+Comments/BTIG+Upgrades+Checkpoint+Software+%28CHKP%29+to+Buy/14384274.html\" target=\"_blank\">upgrades</a> Checkpoint Software (NASDAQ:<a href='https://seekingalpha.com/symbol/CHKP' title='Check Point Software Technologies Ltd.'>CHKP</a>) from Neutral to Buy with a $120 price target, a nearly 18% upside to yesterday&rsquo;s close.</li><li>               Analyst Joel Fishbein says, &ldquo;After 3 quarters of stagnant stock performance and 4 quarters of disappointing guidance from Check Point, we believe it is now time to get constructive on the name again.&rdquo;&nbsp;</li><li>               The analyst notes that the firm was &ldquo;looking for incremental evidence of increased salesforce effectiveness and for signals of a trough in expectations before reassessing&rdquo; the outlook and now believes both criteria are true.&nbsp;</li><li>               The price target implies 15x EV/F18 FCF.&nbsp;</li><li>Check Point shares are&nbsp;<font color='green'>up 1%</font>&nbsp;premarket to $103.02&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3368832\" data-linked=\"BTIG upgrades Check Point Software with 18% upside\" data-tweet=\"$CHKP - BTIG upgrades Check Point Software with 18% upside https://seekingalpha.com/news/3368832-btig-upgrades-check-point-software-18-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3368832-btig-upgrades-check-point-software-18-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368830\" data-ts=\"1531221958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368830-tesla-closes-in-on-china-plant-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla closes in on China plant deal</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is higher in early trading after the company is reported by Bloomberg to have <a href=\"https://www.bloomberg.com/news/articles/2018-07-10/tesla-plans-china-plant-with-an-annual-capacity-of-500-000-cars\" target=\"_blank\">plans</a> in place for a plant in China with capacity for 500K cars produced per year.</li> <li>Sources say Tesla is due to sign a memorandum of understanding with Shanghai entities on the plant.</li><li>Elon Musk is due to visit Shanghai today and Beijing later this week.</li> <li>TSLA <font color='green'>+1.40%</font> to $322.59.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368830\" data-linked=\"Tesla closes in on China plant deal\" data-tweet=\"$TSLA - Tesla closes in on China plant deal https://seekingalpha.com/news/3368830-tesla-closes-in-on-china-plant-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3368830-tesla-closes-in-on-china-plant-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>298&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368806\" data-ts=\"1531218064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368806-pepsicos-beat-q1-estimates-reaffirms-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo&#39;s beat Q1 estimates, reaffirms FY2018 guidance</a></h4><ul><li>PepsiCo (NYSE:<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo Inc.'>PEP</a>) reports organic revenue growth of 2.6% in <a href=\"https://seekingalpha.com/pr/17211156-pepsico-reports-second-quarter-2018-results\" target=\"_blank\">Q2</a>.</li><li>Foreign exchange translation positively impacted revenue by 1%.</li><li>Revenue by segment: Frito-Lay North America: $3.84B (+4%); Quaker Foods North America: $527M (-5%); Latin America: $1.84B (+1%);&nbsp;North America Beverages: $5.2B (-1%);&nbsp;Europe Sub-Saharan Africa: $3.12B (+11%); AMEA: $1.57B (-2%).</li><li>Latin America operating profit&nbsp;up 18% to $269M.</li><li>Asia, Middle East and North Africa&nbsp;operating profit&nbsp;advanced 61% to $496M.</li><li>Total core gross margin contracted 35 bps to 54.8%.</li><li>Total core operating margin flat at 19%.</li><li><b>FY2018 Guidance</b>: Organic revenue growth: in line Y/Y; Core EPS: $5.70; Tax rate: low 20s; Net capital expenditure: ~$3.6B; Cash flow from operating activities: ~$9B; Free cash flow: ~$6B.</li><li>PEP<font color='green'> +0.92%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368803-pepsico-beats-0_09-beats-revenue\" target=\"_blank\">PepsiCo beats by $0.09, beats on revenue</a> (July 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368806\" data-linked=\"PepsiCo&#39;s beat Q1 estimates, reaffirms FY2018 guidance\" data-tweet=\"$PEP - PepsiCo&#39;s beat Q1 estimates, reaffirms FY2018 guidance https://seekingalpha.com/news/3368806-pepsicos-beat-q1-estimates-reaffirms-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3368806-pepsicos-beat-q1-estimates-reaffirms-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}